Opposite effects on cytosolic Ca2+ of antitumor phospholipids by induction of calcium influx and activation of endoplasmic reticulum Ca2+-ATPase

Cell Calcium

Volumn 23, Issue 4, 1998, Pages 241-249

  Bergmann, Jutta ^a   Langen, Peter ^a   Thomas, Yvonne ^a   Brachwitz, Hans ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ANTINEOPLASTIC AGENT; CALCIUM ION; CYCLOPIAZONIC ACID; FURA 2; MILTEFOSINE; PHOSPHOLIPID; THAPSIGARGIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST EPITHELIUM; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL LINE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; EXTRACELLULAR CALCIUM; FLUORESCENCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0031835744     PISSN: 01434160     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4160(98)90122-1     Document Type: Article

References (46)

1. Berdel W.E. Membrane-interactive lipids as experimental anticancer drugs. Br J Cancer 1991; 64: 208-211.
2. Powis G. Signalling pathways as targets for anticancer drug development. Pharmacol Ther 1994; 62: 57-95.
3. Brachwitz H., Vollgraf C. Analogs of alkyllysophospholipids: chemistry, effects on the molecular level and their consequences for normal and malignant cells. Pharmacol Ther 1995; 66: 39-82.
4. Zhou X., Arthur G. Effect of 1-O-octadecyl-2-O-methyl-glycerophosphocholine on phosphatidylcholine and phosphatidylethanolamine synthesis in MCF-7 and A549 cells and its relationship to inhibition of cell proliferation. Eur J Biochem 1995; 232: 881-888.
5. Berkovic D., Grunwald U., Menzel W., Unger C., Hiddemann W., Fleer E.A.M. Effects of hexadecylphosphocholine on membrane phospholipid metabolism in human tumour cells. Eur J Cancer 1995; 31A: 2080-2085.
6. Powis G., Hill S.R., Frew T.J., Sherrill K.W. Inhibitors of phospholipid intracellular signaling as antiproliferative agents. Med Res Rev 1995; 15: 121-138.
7. Wieder T., Zhang Z., Geilen C.C., Orfanos C.E., Giuliano A.E., Cabot M.C. The antitumor phospholipid analog, hexadecylphosphocholine, activates cellular phospholipase D. Cancer Lett 1996; 100: 71-79.
8. Überall F., Oberhuber H., Maly K., Zaknun J., Demuth L., Grunicke H.H. Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity. Cancer Res 1991; 51: 807-812.
9. 3 inhibits nuclear factor-Kb activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1-alpha. Cancer Res 1995; 55: 4844-4849.
10. Maly K., Überall F., Schubert C. et al. Interference of new alkylphospholipid analogues with mitogenic signal transduction. Anti-cancer Drug Design 1995; 10: 411-425.
11. Zheng B., Oishi K., Shoji M. et al. Inhibition of protein kinase C, (sodium plus potassium)-activated adenosine triphosphatase, and sodium pump by synthetic phospholipid analogues. Cancer Res 1990; 50: 3025-3031.
12. 2+ signaling by antitumor ether lipid analogues. Cancer Res 1990; 50: 4458-4463.
13. Powis G., Seewald M.J., Gratas C., Melder D., Riebow J., Modest E.J. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues. Cancer Res 1992; 52: 2835-2840.
14. Junghahn I., Bergmann J., Langen P., Thun I., Vollgraf C., Brachwitz H. Effect of ALP analogs on inositol trisphosphate formation in H184 mammary epithelial cells before and after transfection with v-erb B oncogene. Anticancer Res 1995; 15: 449-454.
15. Berggren M.I., Gallegos A., Dressler LA., Modest E.J., Powis G. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues. Cancer Res 1993; 53: 4297-4302.
16. + exchanger activity by an alkyllysophospholipid analogue in a human breast cancer cell line. Biochem Pharmacol 1996; 51: 1153-1158.
17. Lohmeyer M., Workman P. The role of intracellular free calcium mobilization in the mechanism of action of antitumour ether lipids SRI 62-834 and ET-18-OMe. Biochem Pharmacol 1993; 45: 77-86.
18. Boggs K.P., Rock C.O., Jackowski S. Lysophosphatidylcholine attenuates the cytotoxic effects of the antineoplastic phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine. J Biol Chem 1995; 270: 11612-11618.
19. Slaton J.W., Hampton J.A., Selman S.H. Exposure to alkyllysophopholipids inhibits in vitro invasion of transitional cell carcinoma. J Urology 1994; 152: 1594-1598.
20. 3. Cancer Chemother Pharmacol 1994; 34: 175-178.
21. Lohmeyer M., Workman P. Growth arrest vs direct cytotoxicity and the importance of molecular structure for the in vitro anti-tumour activity of ether lipids. Br J Cancer 1995; 72: 277-286.
22. 3. Cancer Chemother Pharmacol 1996; 38: 269-272.
23. 3 and heat. Anticancer Res 1995; 15: 1333-1338.
24. Vandewalle B., Hornez L., Lassalle B., Revillion F., Bertout M., Lefebvre J. Intracellular calcium and breast cancer cell growth and differentiation. Int J Oncol 1993; 2: 613-620.
25. Villereal M.L., Byron K.L. Calcium signals in growth factor signal transduction. Rev Physiol Biochem Pharmacol 1992; 119: 67-121.
26. Kroeger G., Petit P., Zamzami N., Vayssière J., Mignotte B. The biochemistry of programmed cell death. FASEB J 1995; 9: 1277-1287
27. Trump B.F., Berezesky I.K. Calcium-mediated cell injury and cell death. FASEB J 1995; 9: 219-228.
28. Lazenby C.M., Thompson M.G., Hickman J.A. Elevation of leukemic cell intracellular calcium by the ether lipid SRI 62-834. Cancer Res 1990; 50: 3327-3330.
29. Glasser L., Dalton W.S., Fiederlein R.L., Cook P., Powis G., Vogler W.R. Response of human multiple myeloma-derived cell lines to alkyl-lysophospholipid. Exp Hematol 1996; 24: 253-257.
30. 2+ levels. Cell Cakium 1996; 19: 383-390.
31. 2+ concentration in a normal and a breast cancer cell line. Anticancer Res 1994; 14: 1549-1556.
32. Preston G.A., Barren J.C., Biermann J.A., Murphy E. Effects of alterations in calcium homeostasis on apoptosis during neoplastic progression. Cancer Res 1997; 57: 537-542.
33. 2+ concentration by alkylphospho-L-serine analogs: relation to their antiproliferative action. J Lipid Mediat Cell Signal 1997; 15: 103-114.
34. 2(+)-ATPase. Proc Natl Acad Sci USA 1990; 87: 2466-2470.
35. 2+-ATPaSe of sarcoplasmic reticulum. J Biol Chem 1989; 264: 17816-17823.
36. Brachwitz H., Bergmann J., Thomas Y., Berdel W.E., Langen P., Wollny T. Synthesis and cytostatical evaluation of cytidine- and adenosine-5′-hexadecylphosphate and their phosphonate analogs. Chem Phys Lipids 1997; 90: 143-149.
37. Brachwitz H., Ölke M., Bergmann J., Langen P. Alkylphospho-L-serine analogues: synthesis of cytostatically active alkylphosphono derivatives. Bioorg Med Chem Lett 1997; 7: 1739-1742.
38. Brachwitz H., Langen P., Hintsche R., Schildt J. Synthesis, nuclear magnetic resonance spectra and cytostatic properties of halo analogues of alkyllysophospholipids. Chem Phys Lipids 1986; 31: 33-52.
39. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-3450.
40. 2+ indicator fura-2 in smooth muscle. Jpn J Pharmacol 1993; 61: 165-170.
41. Merritt J.E., Jacob R., Hallam T.J. Use of manganese to discriminate between calcium influx and mobilization from internal stores in stimulated human neutrophils. J Biol Chem 1989; 264: 1522-1527.
42. Berridge M.J. Inositol trisphosphate and calcium signalling. Nature 1993; 361: 315-325.
43. Berridge M.J. Capacitative calcium entry. Biochem J 1995; 312: 1-11.
44. Putney Jr J.W. Capacitative calcium entry revisited. Cell Calcium 1990; 11:611-624.
45. 2+ pool depletion. J Biol Chem 1996; 271: 883-888.
46. Gill D.L, Waldron R.T., Ryssikora K.E. et al. Calcium pools, calcium entry, and cell growth. Biosci Rep 1996; 16: 139-157.